Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments

被引：0
|
作者：
Garcia, Jose Luis Rueda [1 ,2 ]
Benitez, Jose Manuel [3 ]
Rey, Iria Baston [4 ]
Sard, Margalida Calafat [5 ]
Ferrer, Cristina Suarez [1 ,2 ]
机构：
[1] Hosp Univ La Paz, Serv Gastroenterol, Unidad EII, Madrid, Spain
[2] Univ La Paz IdiPAZ, Grp Invest Enfermedades Gastrointestinales Inmunom, Inst Invest Hosp, Madrid, Spain
[3] Hosp Univ Reina Sofia, Unidad EII, IMIBIC, Serv Gastroenterol, Cordoba, Spain
[4] Complejo Hosp Univ Santiago De Compostela, Serv Gastroenterol, Unidad EII, Santiago De Compostela, Spain
[5] Hosp Badalona Germans Trias & Pujol, Serv Gastroenterol, Unidad EII, Badalona, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2025年 / 48卷 / 01期
关键词：
VENOUS THROMBOEMBOLISM; THERAPY; EVENTS; UPADACITINIB; METAANALYSIS; MORTALITY;
D O I：
10.1016/j.gastrohep.2024.502257
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism
    Scharrer, Susanna
    Primas, Christian
    Eichinger, Sabine
    Tonko, Sebastian
    Kutschera, Maximilian
    Koch, Robert
    Blesl, Andreas
    Reinisch, Walter
    Mayer, Andreas
    Haas, Thomas
    Feichtenschlager, Thomas
    Fuchssteiner, Harry
    Steiner, Pius
    Ludwiczek, Othmar
    Platzer, Reingard
    Miehsler, Wolfgang
    Tillinger, Wolfgang
    Apostol, Sigrid
    Schmid, Alfons
    Schweiger, Karin
    Vogelsang, Harald
    Dejaco, Clemens
    Herkner, Harald
    Novacek, Gottfried
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1773 - 1783
  • [42] Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease
    Li, Zhihui
    Qiao, Lili
    Yun, Xiaojing
    Du, Fangjuan
    Xing, Shilei
    Yang, Maowu
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 117 - 124
  • [43] The evolving epidemiology of inflammatory bowel disease
    Shanahan, Fergus
    Bernstein, Charles N.
    CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (04) : 301 - 305
  • [44] Cardiovascular risk factors are not present in adolescents with inflammatory bowel disease
    Dorfman, Lev
    Ghersin, Itai
    Khateeb, Neron
    Daher, Saleh
    Shamir, Raanan
    Assa, Amit
    ACTA PAEDIATRICA, 2020, 109 (11) : 2380 - 2387
  • [45] The continuing uncertainty about cancer risk in inflammatory bowel disease
    Adami, Hans-Olov
    Bretthauer, Michael
    Emilsson, Louise
    Hernan, Miguel A.
    Kalager, Mette
    Ludvigsson, Jonas F.
    Ekbom, Anders
    GUT, 2016, 65 (06) : 889 - 893
  • [46] Effect of inflammatory bowel disease treatments on patients with diabetes mellitus
    Bower, Joshua Ashley Jack
    O'Flynn, Lauren
    Kakad, Rakhi
    Aldulaimi, David
    WORLD JOURNAL OF DIABETES, 2021, 12 (08) : 1248 - 1254
  • [47] Optimizing anti-TNF treatments in inflammatory bowel disease
    Ben-Horin, Shomron
    Kopylov, Uri
    Chowers, Yehuda
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 24 - 30
  • [48] The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases
    Jeon, Seong Ran
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 81 (03) : 142 - 144
  • [49] A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments
    Janardhana, Priya
    Al-Kadhi, Saad
    CURRENT OPINION IN OPHTHALMOLOGY, 2021, 32 (06) : 549 - 554
  • [50] Ocular extraintestinal manifestations and treatments in patients with inflammatory bowel disease
    Duran, Mariana Rodriguez
    O'Keefe, Ghazala A. Datoo
    FRONTIERS IN OPHTHALMOLOGY, 2024, 3
12345